Brachytherapy for head and neck cancers (nasopharynx excluded);Curiethérapie des cancers de la tête et du cou (cavum exclu)

Cancer/Radiotherapie

Volumn 12, Issue 6-7, 2008, Pages 515-521

  Lapeyre, M ^a   Belliere A ^a   Hoffstetter, S ^b   Peiffert, D ^b  

^a CENTRE JEAN PERRIN   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Brachytherapy; Cancer; Head and neck; Radiotherapy

Indexed keywords

IRIDIUM;

BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CERVICAL LYMPH NODE; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; LIP CANCER; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MOUTH CANCER; MOUTH CAVITY; OROPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE DISTRIBUTION; RADIATION NECROSIS; RADIATION PROTECTION; SHORT SURVEY; SKIN CARCINOMA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 55649097758     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.08.276     Document Type: Short Survey

References (59)

1. Ahmad F., Aletti P., Charra-Brunaud C., Van der Laarse R., Lapeyre M., Hoffstetter S., et al. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy. Radiother Oncol 73 3 (2004) 331-337
2. Avril M.F., Auperin A., Margulis A., Gerbaulet A., Duvillard P., Benhamou E., et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76 1 (1997) 100-106
3. Beauvois S., Hoffstetter S., Peiffert D., Luporsi E., Carolus J.M., Dartois D., et al. Brachytherapy for lower lip epidermoid cancer: tumoral and treatment factors influencing recurrences and complications. Radiother Oncol 33 3 (1994) 195-203
4. Beitler J.J., Smith R.V., Silver C.E., Quish A., Deore S.M., Mullokandov E., et al. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys 40 2 (1998) 313-317
5. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 19 (2004) 1945-1952
6. Bollet M.A., Lapeyre M., Marchal C., Hoffstetter S., Peiffert D., Cornes P.G., et al. Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option?. Int J Radiat Oncol Biol Phys 51 5 (2001) 1305-1312
7. Chao K.S., Emami B., Akhileswaran R., Simpson J., Spector G., and Sessions D. The impact of surgical margin status and use of an interstitial implant on T1,T2 oral tongue cancers after surgery. Int J Radiat Oncol Biol Phys 36 5 (1996) 1039-1043
8. Conill C., Verger E., Marruecos J., Vargas M., and Biete A. Low dose rate brachytherapy in lip carcinoma. Clin Transl Oncol 9 4 (2007) 251-254
9. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 19 (2004) 1937-1944
10. Crook J., Mazeron J.J., Marinello G., Martin M., Raynal M., Calitchi E., et al. Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Creteil experience (1971-1981). Int J Radiat Oncol Biol Phys 15 1 (1988) 105-114
11. de Pree C., Popowski Y., Weber D., Nouet P., Rouzaud M., and Kurtz J.M. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 43 5 (1999) 971-976
12. Donath D., Vuong T., Shenouda G., MacDonald B., and Tabah R. The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer. Eur Arch Otorhinolaryngol 252 6 (1995) 321-324
13. Fontanesi J., Hetzler D., and Ross J. Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192. Int J Radiat Oncol Biol Phys 17 2 (1989) 365-369
14. Gerbaulet A., Potter R., Mazeron J.J., Meertens H., and Van Limbergen E. The GEC ESTRO handbook of brachytherapy (2002), ACCO, Leuven
15. Hepel J.T., Syed A.M., Puthawala A., Sharma A., and Frankel P. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 62 5 (2005) 1444-1450
16. Hoffstetter S., Marchal C., Peiffert D., Luporsi E., Lapeyre M., Pernot M., et al. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol 45 2 (1997) 141-148
17. Inoue T., Inoue T., Yoshida K., Yoshioka Y., Shimamoto S., Tanaka E., et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 51 1 (2001) 171-175
18. Kolotas C., Tselis N., Sommerlad M., Roddiger S., Schnabel T., Baltas D., et al. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 183 2 (2007) 69-75
19. Kupferman M.E., Morrison W.H., Santillan A.A., Roberts D., Diaz Jr. E.M., Garden A.S., et al. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 109 10 (2007) 2052-2057
20. Lapeyre M., Bollet M.A., Racadot S., Geoffrois L., Kaminsky M.C., Hoffstetter S., et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 26 3 (2004) 216-223
21. Lapeyre M., Hoffstetter S., Peiffert D., Guerif S., Maire F., Dolivet G., et al. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 48 1 (2000) 37-42
22. Lapeyre M., Peiffert D., and Hoffstetter S. Postoperative brachytherapy: a prognostic factor for local control in epidermoid carcinomas of the mouth floor. Eur J Surg Oncol 23 (1997) 243-246
23. Lapeyre M., Peiffert D., Hoffstetter S., Pernot M., Dolivet G., Simon C., et al. Post-operative brachytherapy: a prognostic factor for local control in epidermoid carcinomas of the mouth floor. Eur J Surg Oncol 23 3 (1997) 243-246
24. Lau H.Y., Hay J.H., Flores A.D., and Threlfall W.J. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 39 1 (1996) 15-18
25. Leung T.W., Wong V.Y., Wong C.M., Tung S.Y., Tsang A., Lowes M., et al. Technical hints for high dose rate interstitial tongue brachytherapy. Clin Oncol (R Coll Radiol) 10 4 (1998) 231-236
26. Levendag P.C., Meeuwis C.A., and Visser A.G. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 23 1 (1992) 6-15
27. Levendag P.C., Schmitz P.I., Jansen P.P., Senan S., Eijkenboom W.M., Sipkema D., et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 38 3 (1997) 497-506
28. Martinez-Monge R., Alcalde J., Concejo C., Cambeiro M., and Garran C. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: initial results of a phase I/II reirradiation study. Brachytherapy 5 1 (2006) 32-40
29. Mazeron J.J., Crook J.M., Benck V., Marinello G., Martin M., Raynal M., et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 19 6 (1990) 1369-1376
30. Mazeron J.J., Crook J.M., Marinello G., Walop W., and Pierquin B. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys 19 2 (1990) 281-285
31. Mazeron J.J., Grimard L., Raynal M., Haddad E., Piedbois P., Martin M., et al. Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth. Int J Radiat Oncol Biol Phys 18 6 (1990) 1299-1306
32. Mazeron J.J., Noel G., Simon J.M., Racadot S., and Jauffret E. Brachytherapy in head and neck cancers. Cancer Radiother 7 1 (2003) 62-72
33. Mazeron J.J., Simon J.M., and Le Péchoux C. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial Iridium 192. Radiother Oncol 21 (1991) 39-47
34. Melzner W.J., Lotter M., Sauer R., and Strnad V. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?. Radiother Oncol 82 2 (2007) 167-173
35. Mendenhall W.M., Parsons J.T., Stringer S.P., Cassisi N.J., and Million R.R. T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radiother Oncol. 16 4 (1989) 275-281
36. Nag S., Cano E.R., Demanes D.J., Puthawala A.A., and Vikram B. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 50 5 (2001) 1190-1198
37. Nag S., Koc M., Schuller D.E., Tippin D., and Grecula J.C. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers. Brachytherapy 4 3 (2005) 217-223
38. Nag S., Martinez-Monge R., Zhang H., and Gupta N. Simplified non-looping functional loop technique for HDR brachytherapy. Radiother Oncol 48 3 (1998) 339-341
39. Nose T., Koizumi M., and Nishiyama K. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 59 4 (2004) 983-991
40. Nutting C., Horlock N., A'Hern R., Searle A., Henk J.M., Rhys-Evans P., et al. Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 80 1 (2006) 39-42
41. Peiffert D., Castelain B., Thomas L., Ardiet J.M., Baillet F., and Mazeron J.J. Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group. Radiother Oncol 58 1 (2001) 71-75
42. Peiffert D., Pernot M., Malissard L., Aletti P., Hoffstetter S., Kozminski P., et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 29 4 (1994) 681-686
43. Pellizzon A.C., dos Santos Novaes P.E., Conte Maia M.A., Ferrigno R., Fogarolli R., Salvajoli J.V., et al. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 27 12 (2005) 1035-1041
44. Pellizzon A.C., Salvajoli J.V., Kowalski L.P., and Carvalho A.L. Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol 1 (2006) 27
45. Pernot M., Aletti P., Carolus J.M., Marquis I., Hoffstetter S., Maaloul F., et al. Indications, techniques and results of postoperative brachytherapy in cancer of the oral cavity. Radiother Oncol 35 3 (1995) 186-192
46. Pernot M., Hoffstetter S., Peiffert D., Luporsi E., Marchal C., Kozminski P., et al. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 35 3 (1995) 177-185
47. Pernot M., Luporsi E., Hoffstetter S., Peiffert D., Aletti P., Marchal C., et al. Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol Phys 37 3 (1997) 577-585
48. Pernot M., Malissard L., Aletti P., Hoffstetter S., Forcard J.J., and Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 23 4 (1992) 223-228
49. Pernot M., Malissard L., Hoffstetter S., Luporsi E., Aletti P., Peiffert D., et al. Influence of tumoral, radiobiological, and general factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation + brachytherapy or brachytherapy alone). Int J Radiat Oncol Biol Phys. 30 5 (1994) 1051-1057
50. Pernot M., Malissard L., Hoffstetter S., Luporsi E., Peiffert D., Aletti P., et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 29 4 (1994) 673-679
51. Petit J.Y., Avril M.F., Margulis A., Chassagne D., Gerbaulet A., Duvillard P., et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 105 7 (2000) 2544-2551
52. Pierquin B., and Marinello G. Manuel pratique de curiethérapie (1992), Hermann, Paris
53. Puthawala A., Nisar Syed A.M., Gamie S., Chen Y.J., Londrc A., and Nixon V. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys. 51 2 (2001) 354-362
54. Rio E., Bardet E., Ferron C., Peuvrel P., Supiot S., Campion L., et al. Interstitial brachytherapy of peri-orificial skin carcinomas on the face. Cancer Radiother 10 3 (2006) 101-106
55. Rovirosa-Casino A., Planas-Toledano I., Ferre-Jorge J., Oliva-Diez J.M., Conill-Llobet C., and Arenas-Prat M. Brachytherapy in lip cancer. Med Oral Patol Oral Cir Bucal. 11 3 (2006) E223-E229
56. Simon J.M., Mazeron J.J., Pohar S., Le Pechoux C., Crook J.M., Grimard L., et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 26 1 (1993) 19-25
57. Strnad V., Lotter M., Grabenbauer G., and Sauer R. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys 46 1 (2000) 27-30
58. Strnad V., Melzner W., Geiger M., Zenk J., Waldfahrer F., Lotter M., et al. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients. Strahlenther Onkol 181 12 (2005) 762-767
59. Ziemlewski A., Zienkiewicz J., Serkies K., and Badzio A. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer. Strahlenther Onkol 183 9 (2007) 512-516